Kulkarni Samarth sold CRSP

September 17, 2025 · Form 4 insider transaction

Kulkarni Samarth sold 6,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Disposed (sell-side)

6,000

Price

$0.00

Total value

N/A

InsiderKulkarni Samarth

RoleOfficer, Director

CompanyCRISPR Therapeutics AG (CRSP)

SecurityCommon Shares

Transaction codeG — Gift

Transaction dateSeptember 17, 2025

Filing dateSeptember 19, 2025

Shares owned after201,004

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

The reporting person made a charitable contribution of common shares to a donor advised fund.

View the original Form 4 on SEC EDGAR